    John Docherty | Helix BioPharma Corp. | ZoomInfo.com


Insider Trading - Docherty John Martin - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Docherty John Martin





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2015-03-26Purchase
2016-06-248:37 pm
Lexaria Bioscience Corp.
LXRP
Docherty John MartinPresidentDirector
210,000
$0.1
$21,000
850,000(IndirectDirect)
View


2015-03-26Purchase
2015-08-243:27 pm
Lexaria CORP.
LXRP
Docherty John MartinPresident
420,000
$0.2
$84,000
630,000(Indirect)
View


2015-03-26Purchase
2015-07-234:48 pm
Lexaria CORP.
LXRP
Docherty John MartinPresident
500,000
$0.17
$85,000
630,000(Indirect)
View


2015-03-26Purchase
2015-05-226:03 pm
Lexaria CORP.
LXRP
Docherty John MartinPresident
130,000
$0.1
$13,000
130,000(Indirect)
View




Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2015-03-26Option Award
2016-10-115:11 pm
N/AN/A
Lexaria Bioscience Corp.
LXRP
Docherty John MartinPresidentDirector
252,000
$0.14
1,067,000(Indirect)
View


2015-03-26Purchase
2016-06-248:37 pm
2016-04-152017-04-15
Lexaria Bioscience Corp.
LXRP
Docherty John MartinPresidentDirector
300,000
$0.11
850,000(Direct)
View


2015-03-26Option Award
2015-12-186:16 pm
N/AN/A
Lexaria CORP.
LXRP
Docherty John MartinPresident
55,000
$0
605,000(Indirect)
View


2015-03-26Option Award
2015-12-186:16 pm
2015-03-262020-03-26
Lexaria CORP.
LXRP
Docherty John MartinPresident
50,000
$0.09
605,000(Direct)
View


2015-03-26Option Award
2015-12-186:16 pm
2015-05-152017-05-15
Lexaria CORP.
LXRP
Docherty John MartinPresident
13,000
$0.23
605,000(Indirect)
View


2015-03-26Disposition
2015-08-243:27 pm
N/AN/A
Lexaria CORP.
LXRP
Docherty John MartinPresident
500,000
$0.17
630,000(Indirect)
View


2015-03-26Purchase
2015-05-226:03 pm
2015-05-152017-05-15
Lexaria CORP.
LXRP
Docherty John MartinPresident
130,000
$0.25
130,000(Indirect)
View


2015-03-26Purchase
2015-04-073:18 pm
2015-03-262020-03-26
Lexaria CORP.
LXRP
Docherty John MartinPresident
500,000
$0.1
500,000(Direct)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Fri, 28 Jul 2017 06:52:45 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  









Lexaria Bioscience Corp (LXRP.PK)  People | Reuters.com


























































X



Edition:

United States


















Africa
América Latina


عربي
Argentina


Brasil
Canada


中国
Deutschland


España
France


India
Italia


日本
México


РОССИЯ
United Kingdom

United States
















Lexaria Bioscience Corp (LXRP.PK)










Related Topics: 
StocksStock ScreenerMarket DataConsumer Non-CyclicalsFood Processing












                
                        Overview
                    



                
                        News
                    



                
                        Key Developments
                    



                
                        People
                    



                
                        Charts
                    



                
                        Financials
                    



                
                        Analysts
                    



                    
                            Research
                        



                    
                            Pulse
                        










				LXRP.PK on OTC Markets Group


				0.37USD
27 Jul 2017





				    Change	(% chg)


		    
						    --


					            (--)
					        






Prev Close

$0.37


Open

--




Day's High

--


Day's Low

--




Volume

--


Avg. Vol

125,176




52-wk High

$0.70


52-wk Low

$0.09











					Summary





Name
Age
Since
Current Position




							Christopher Bunka

52
2017

                                Chairman of the Board, Chief Executive Officer




							John Docherty

46
2016

                                President, Director




							Allan Spissinger


2017

                                Acting Chief Financial Officer, Treasurer, Secretary




							Ted McKechnie


2015

                                Director




							Nicholas Baxter


2011

                                Independent Director



» Insider Trading





					Biographies





Name
Description




							Christopher Bunka


					
							Mr. Christopher A. Bunka is Chairman of the Board, Chief Executive Officer of Lexaria Corp., Mr. Bunka is no longer President of the Company. He has completed both equity and debt financings for company, completed the acquisition of additional oil & gas assets, disposed of other oil & gas assets, and restructured company. He has refocused company from one of natural gas exploration to that of development of existing oil reserves, and has engaged additional geophysical in an attempt to better understand its exploration and development opportunities. Mr. Bunka has privately evaluated numerous oil and gas properties and investment opportunities for his private investments during the past 10 years. Since 1988, Mr. Bunka has been the CEO of CAB Financial Services Ltd., a private holding company located in Kelowna, Canada. He is a venture capitalist and corporate consultant. From 1999 to 2002, Mr. Bunka was the President and CEO of Secure Enterprise Solutions (symbol SETP-OTC) (formerly Newsgurus.com, symbol NGUR-OTC). The Company subsequently changed its name to Edgetech Services and traded on the OTC with the symbol EDGH. Newsgurus.com was a web-based media company. Secure Enterprise Solutions moved into Internet-based computer security products and services and was subsequently purchased by Edgetech Services. Mr Bunka is also Chairman/CEO of Enertopia Corp, (symbol ENRT-OTC) a clean energy company. Mr. Bunka is a director of Defiance Capital Corp., (symbol DEF-TSXV) a Canadian resource company.




							John Docherty


					
							Mr. John Martin Docherty, M.Sc. is President, Director of Lexaria Corp., Mr. Docherty was former President and Chief Operating officer of Helix BioPharma Corp. (TSX: HBP), where he led the company’s pharmaceutical development programs for its plant and recombinantly derived therapeutic protein product candidates. Mr. Docherty is a senior operations and management executive with a wealth of experience in the pharmaceutical and biopharmaceutical sectors. He has worked with large multinational companies and emerging, private and publicly held, Canadian startups; and he also brings specialized knowhow in the field of naturally-derived products and technologies specifically. Mr. Docherty has over twenty years’ experience in the pharmaceutical and biopharmaceutical industries. At Helix, Mr. Docherty was also instrumental in the areas of investor/stakeholder relations, capital raising, capital markets development, strategic partnering, regulatory authority interactions and media relations, and he also served as a management member of its board of directors. Prior to this, Mr. Docherty was President and a board member of PharmaDerm Laboratories Ltd., a Canadian drug delivery company that developed unique microencapsulation formulation technologies for use with a range of active compounds. Mr. Docherty has also held positions with companies such as Astra Pharma Inc., Nu-Pharm Inc. and PriceWaterhouseCoopers’ former global pharmaceutical industry consulting practice. He is a named inventor on issued and pending patents and he has a M.Sc. in pharmacology and a B.Sc. in Toxicology from the University of Toronto.




							Allan Spissinger


					
							Mr. Allan Spissinger is Acting Chief Financial Officer, Treasurer, Secretary of the company. He was involved in the information technologies (IT) sector for more than 10 years working on corporate IT infrastructure and software development projects before focusing on finance and accounting. Allan joined the audit and assurance practice of PricewaterouseCoopers (PwC) obtaining his Chartered Professional Accountant (CPA) designation by working primarily in the public company space on financial reporting and Sarbanes-Oxley (SOX) compliance in sectors including resources, manufacturing and technologies.




							Ted McKechnie


					
							Mr. Ted McKechnie is Director of Lexaria Corp. Mr. McKechnie is a senior entrepreneurial executive with extensive board and senior management experience in the consumer goods industry, with a proven record of achieving corporate financial and growth objectives. He is the former president and chief operating officer of Maple Leaf Foods, which in 2014 had revenue of over $3.1-billion. Mr. McKechnie has held executive positions with Kraft, Frito Lay, General Foods, PepsiCo and Philip Morris Companies. He is the founder, chairman and chief executive officer of Canada's Technology For Food. He is an energetic leader experienced in building teams in marketing, sales and supply chain management. He is the recipient of the Philip Morris Chairman's Award for "recognition of extraordinary contributions having a significant and lasting impact on the corporation." Mr. McKechnie will contribute to Lexaria's pursuit of excellence in hemp oil fortified food manufacturing, as well as assisting in opening retail distribution channels.




							Nicholas Baxter


					
							Mr. Nicholas W. Baxter is Independent Director of Lexaria Corp. Mr. Baxter has been in the oil & gas business for 30 years. Mr. Baxter received a Bachelor of Science (Honors) from the University of Liverpool in 1975. Mr. Baxter has worked on geophysical survey and exploration projects in the U.K., Europe, Africa and the Middle East. From 1981 to 1985, Mr. Baxter worked for Resource Technology plc, a geophysical equipment sales/services company that went public on the USM in London in 1983 and graduated to the London Stock Exchange in 1984. Mr. Baxter established his own company in 1985 as a co-founder of Addison & Baxter Limited, a private geophysical/geological sales and services company which was acquired by A&B Geoscience Corporation in 1992. Mr. Baxter was Chief Operating Officer and a director of A&B Geoscience Corporation from 1992 to 2002. Mr. Baxter worked as an independent upstream oil and gas consultant from 2002 to 2004. He joined Eurasia Energy Ltd in 2005, where he is currently President and Chief Executive Officer.











					Basic Compensation





Name
Fiscal Year Total




							Christopher Bunka

105,585




							John Docherty

--




							Allan Spissinger

--




							Ted McKechnie

--




							Nicholas Baxter

--



As Of 
30 Oct 2013





					Options Compensation





Name
Options
Value




							Christopher Bunka

0
0




							John Docherty

0
0




							Allan Spissinger

0
0




							Ted McKechnie

0
0




							Nicholas Baxter

0
0









					Insider Trading












Name
Shares Traded
Price


Docherty (John Martin)
210,000
$0.30


Bunka (Christopher A)
210,000
$0.30


McKechnie (William Edward)
35,249
$0.34


McKechnie (William Edward)
114,286
$0.14


Docherty (John Martin)
252,000
$0.14


Bunka (Christopher A)
5,000
$0.13


Bunka (Christopher A)
5,000
$0.12


Bunka (Christopher A)
10,000
$0.13


Bunka (Christopher A)
2,500
$0.15


Bunka (Christopher A)
5,100
$0.13


Bunka (Christopher A)
5,000
$0.13


Bunka (Christopher A)
14,637
$0.12


Bunka (Christopher A)
5,000
$0.14


Bunka (Christopher A)
3,000
$0.13


Bunka (Christopher A)
9,300
$0.13


Bunka (Christopher A)
10,500
$0.13


Bunka (Christopher A)
2,000
$0.15


Bunka (Christopher A)
11,340
$0.13


Bunka (Christopher A)
10,000
$0.15


Bunka (Christopher A)
450,000
$0.06


Bunka (Christopher A)
5,000
$0.13


Bunka (Christopher A)
19,083
$0.11


Bunka (Christopher A)
5,000
$0.15


Bunka (Christopher A)
6,400
$0.13


Bunka (Christopher A)
1,100
$0.12




» Full list on Insider Trading
















Related Topics: 
StocksStock ScreenerMarket DataConsumer Non-CyclicalsFood Processing























LXRP John Martin Docherty Insider Trades for Lexaria Bioscience Corp.


































Bulletin






Investor Alert







New York Markets Open in:



Market Snapshot
Analyst Ratings


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Lexaria Bioscience Corp.

                  OTC: LXRP
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Lexaria Bioscience Corp.



Market closed
 --Quotes are delayed by 20 min
Jul 27, 2017, 5:20 p.m.


LXRP

/quotes/zigman/63145195/delayed


$
0.37




Change

+0.0099
+2.75%

Volume
Volume 79,832
Quotes are delayed by 20 min








/quotes/zigman/63145195/delayed
Previous close

$
			0.36
		


$
				0.37
			
Change

+0.0099
+2.75%





Day low
Day high
$0.34
$0.37










52 week low
52 week high

            $0.09
        

            $0.70
        


















Insider Activity


Individual




John Martin Docherty



Mr. John M. Docherty is on the Board of Directors at Lexaria Bioscience Corp. Mr. Docherty was previously employed as President by PharmaDerm Laboratories Ltd. and Chief Operating Officer by Helix BioPharma Corp. He received his undergraduate degree from the University of Toronto and a graduate degree from the University of Toronto.



Transactions


Date
Shares
Transaction
Value





06/22/2017
210,000


 
Award at $0.3 per share.


63,000


10/11/2016
252,000


 
Award at $0.14 per share.


35,280


04/15/2016
210,000


 
Acquisition at $0.1 per share.


21,000


12/16/2015
55,000


 
Award at $0 per share.


0


08/17/2015
420,000


 
Acquisition at $0.2 per share.


84,000


08/17/2015
500,000


 



85,000


07/22/2015
500,000


 
Acquisition at $0.17 per share.


85,000


05/15/2015
130,000


 
Acquisition at $0.1 per share.


13,000





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Mr. Christopher A. Bunka 
Chairman & Chief Executive Officer




Mr. John Martin Docherty 
President & Director




Mr. Allan  Spissinger 
Chief Financial Officer, Secretary & Treasurer




Ms. William Edward McKechnie 
Independent Director




Mr. Nicholas W. Baxter 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




7:52 AM EDT
July 28, 2017


/marketstate/country/us
New York

	Pre


/marketstate/country/uk
London

	Open


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
7:52aWatch out: ‘Kids’ are making the most money in this stock market 
7:51aStock market set to extend fresh tech rout as Amazon disappoints; GDP data ahead
7:49aShares of video game maker Activision Blizzard down more than 1% 
7:49aIntel earnings have message for AMD and Nvidia: ‘Bring it on’
7:48aAaron's shares up nearly 6% in Friday premarket trading
7:48aAmazon’s free-spending ways hit earnings, but don’t expect a shift to thrift
7:46aAbbVie shares up 1.8% in premarket trade
7:46aAbbVie still sees full-year adj. EPS $5.44 to $5.54
7:46aAbbVie still sees full-year EPS $4.55 to $4.65
7:45aAbbVie Q2 revenue $6.94 bln vs. $6.45 bln; FactSet consensus $6.93 bln
7:44aAbbVie Q2 adj. EPS $1.42; FactSet consensus $1.40
7:44aGoodyear's stock plunges 9.1% premarket after Q2 results
7:44aAbbVie Q2 EPS $1.19 vs. 98 cents
7:44aGoodyear cuts 2017 segment operating income outlook to $1.60 bln-$1.65 bln from $2.0 bln
7:43aGet ready for the less-profitable Amazon that you used to know 
7:42aWells Fargo charged customers for duplicate car insurance
7:42aGoodyear Q2 sales $3.69 bln vs. $3.88 bln; FactSet consensus $3.73 bln
7:42aCORRECT: Goodyear Q2 adj. EPS 70 cents; FactSet consensus 70 cents
7:40aGoodyear Tire & Rubber Q2 EPS 58 cents vs. 75 cents a year ago
7:40aAmerican Air shares jump 3% after profit beat
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,796.55

+85.54
+0.39%





nasdaq

/quotes/zigman/12633936/realtime
6,382.19

-40.56
-0.63%





s&p 500

/quotes/zigman/3870025/realtime
2,475.42

-2.41
-0.10%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15
























































JOHN MARTIN  DOCHERTY - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











JOHN MARTIN  DOCHERTY
Check out list of companies and businesses related to JOHN MARTIN  DOCHERTY. Find out JOHN MARTIN  DOCHERTY address and contact details. View other people related to JOHN MARTIN  DOCHERTY - coworkers, colleagues, companions, etc.
Address:   

23 MIKELEN DRIVE  PORT PERRY L9L 1V1 A6




Companies related to JOHN MARTIN  DOCHERTY
CIKCompany NamePositionCompany Address0001348362Lexaria Bioscience Corp.President 156 VALLEYVIEW ROAD  KELOWNA V1X 3M4




JOHN MARTIN  DOCHERTY on the Web
Persons related to JOHN MARTIN  DOCHERTY - Lexaria Bioscience Corp.NamePositionCityNicholas W  BaxterDirector BUCKINGHAMSHIRENicholas W  BaxterDirector ABERDEENSHIRE, SCOTLANDNicholas W  BaxterDirector ABERDEENSHIRE, SCOTLANDBaljinder  BhullarCFO JACKSONVILLEBaljinder  BhullarCFO VANCOUVERBaljinder  BhullarCFO VANCOUVERBaljinder  BhullarCFO VANCOUVERCHRISTOPHER  BUNKACEO KELOWNACHRISTOPHER  BUNKAPresident KELOWNACHRISTOPHER  BUNKAPresident KELOWNACHRISTOPHER  BUNKAPresident KELOWNABunka  ChristopherVancouverDAVID  DEMARTINIDirector HOUSTONJOHN MARTIN  DOCHERTYPresident PORT PERRYDUSTIN ARTHUR  ELFORDVANCOUVERTHOMAS JAMES  IHRKESr. VP, Business Developement MOUNT PLEASANTDocherty  JohnVancouverLeonard  MacMillanVice President-Corp Develop VANCOUVERWilliam Edward  McKechnieDirector KITCHENERBaxter  NicholasAberdeen, ScotlandDiane  ReesWEST VANCOUVERAllan Horst  SpissingerCFO LANGLEYMcKechnie  TedKitchener
Potentially same personNameCityCountryMARTIN  JOHNMILWAUKEEWIMartin  JohnSalt Lake CityUTMartin  JohnSan MateoCAMartin  JohnChicagoILMartin  JohnPittsburghPAMartin  JohnMuncieINMartin  JohnDallasTXMartin  JohnChicagoILMartin  JohnBurlingameCAMartin  JohnAustinTXMartin  JohnAustinTXMartin  JohnAustinTXMartin  JohnPittsburghPAMartin  JohnBurlingameCAMartin  JohnCovingtonLAMartin  JohnNew YorkNYMartin  JohnAustinTXMartin  JohnWalthamMAMartin  JohnNew YorkNYMARTIN  JOHNGREENWOOD VILLAGECO












 







Security Check Required




FacebookJoin or Log Into Facebook   Email or PhonePasswordForgot account?Log InDo you want to join Facebook?Sign UpSign UpSecurity CheckPlease enter the text belowCan't read the text above?Try another text or an audio captchaText in the box:What's this?Security CheckThis is a standard security test that we use to prevent spammers from creating fake accounts and spamming users.SubmitEnglish (US)EspañolFrançais (France)中文(简体)العربيةPortuguês (Brasil)Italiano한국어Deutschहिन्दी日本語MessengerFacebook LitePeoplePlacesGamesLocationsCelebritiesMarketplaceGroupsRecipesMomentsInstagramAboutCreate AdCreate PageDevelopersCareersPrivacyCookiesAd ChoicesTermsSettingsActivity Log Facebook © 2017





Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft












DOCHERTY JOHN MARTIN Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      DOCHERTY JOHN MARTIN
                    

•   PORT PERRY, A6
                      
How do I update this listing?




                                             Docherty John Martin is based out of Port Perry.   
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from DOCHERTY JOHN MARTIN, enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




docherty john martin


23 MIKELEN DRIVE

PORT PERRY
A6
                                                        
                                                    L9L 1V1









Recent SEC Filings




4 filed on 06/22/2017
4 filed on 05/18/2017
4 filed on 10/11/2016
4 filed on 06/24/2016
4 filed on 12/18/2015
4 filed on 08/24/2015
4 filed on 07/23/2015
4 filed on 05/22/2015
4 filed on 04/07/2015
















Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free


















Martin Docherty Profiles | Facebook

FacebookEmail or PhonePasswordForgot account?English (US)EspañolFrançais (France)中文(简体)العربيةPortuguês (Brasil)Italiano한국어Deutschहिन्दी日本語MessengerFacebook LitePeoplePlacesGamesLocationsCelebritiesMarketplaceGroupsRecipesMomentsInstagramAboutCreate AdCreate PageDevelopersCareersPrivacyCookiesAd ChoicesTermsSettingsActivity Log Facebook © 2017





















John Martin Docherty - Biography

















































































Log in






E-mail



Password







Remember




Forgot password ?









Become a member for free
Sign up





Sign up




New memberSign up for FREE


New customerDiscover our portfolios












 United States
 United Kingdom
 France
 Deutschland
 Schweiz (DE)
 Suisse (FR)










Settings

            Dynamic quotes 


OFFON

















Markets
Equities
North AmericaEuropeAsiaOceaniaMiddle East» More Equities

Indexes
DOW JONESS&P 500NASDAQ 100TSX COMPFTSE 100» More Indexes

Currency / Forex
EUR / USDGBP / USDUSD / JPYUSD / CADAUD / USD» More Currencies

Commodities
GOLDCrude Oil (WTI)Crude Oil (BRENT)SILVERPLATINUM» More Commodities


 News
Latest News
CompaniesMarketsEconomyCurrency / ForexCommoditiesInterest RatesBusiness LeadersFinancial calendarEconomic calendar

Listed company
Analyst reco.RumorsIPOsCapital Markets TransactionsNew ContractsProfits warningsAppointmentsPress ReleasesEventsCorporate actions

Sector News
EnergyBasic MaterialsIndustrialsConsumer CyclicalConsumer Non-CyclicalFinancialsHealthcareTechnologyTelecommunications ServicesUtilities


 Analysis
All AnalysisCommentariesIndex AnalysisStock Trading StrategiesCommodity AnalysisForex Analysis

 Stock Picks
All stock picks

 Portfolios
My Portfolio
Virtual portfolios
4-Traders Portfolios
European PortfolioUSA PortfolioAsian Portfolio


 Screeners
Market Screener HomeFundamental Analyse
Top Investor RatingTop Trading RatingTop ConsensusGrowth stocksYield stocksLow valuations

Technical Analysis
Oversold stocksOverbought stocksClose to resistancesClose to supportsAccumulation phaseMost volatile stocks


 Watchlists
My Watchlists
Watchlists
Top Lists
Yield stocksGrowth stocksUndervalued Stocks


 Top / Flop
Top News
Most Read NewsHot News

Top Fundamentals
Top CapitalizationTop YieldTop PERTop ConsensusTop Fundamentals

Top Technicals
Top RSIUnusual volumesTop GapsTop STIM

Top Movers
Top USATop CanadaTop U.K.Top GermanyTop EuropeTop Asia


 Tools
Market ScreenerDynamic chartFinancial calendarEconomic calendarSector researchCurrency converter

 Our Services
Premium AccessDiscover our Services

 



















 






4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography


Business Leaders




Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors HomeAll newsMost read newsBusiness Leaders Biography


 
















John Martin Docherty

Age : 48Public asset : 386,931 USDLinked companies :  Lexaria Bioscience Corp 





Summary 



Mr. John M. Docherty is on the Board of Directors at Lexaria Bioscience Corp. Mr. Docherty was previously employed as President by PharmaDerm Laboratories Ltd. and Chief Operating Officer by Helix BioPharma Corp.He received his undergraduate degree from the University of Toronto and a graduate degree from the University of Toronto.



Current positions of John Martin Docherty 









 NameTitle
Since
 Lexaria Bioscience Corp
President & Director
2015



Holdings of John Martin Docherty 










 NameEquities%Valuation

 Lexaria Bioscience Corp (LXRP)1,277,0001.92%386,931 USD



John Martin Docherty: Personal Network 







 NameLinked companies

Christopher A. Bunka Lexaria Bioscience Corp 

Nicholas W. Baxter Lexaria Bioscience Corp 

William Edward McKechnie Lexaria Bioscience Corp 

Allan Spissinger Lexaria Bioscience Corp 

Howard Bubb Lexaria Bioscience Corp 

Leonard MacMillan Lexaria Bioscience Corp 

Baljinder Bhullar Lexaria Bioscience Corp 




Most Read News 




07/21DJMUKESH AMBANI : Reliance's Ambani Launches Low-Cost Mobile Phone for India



07/21DJINDRA NOOYI : PepsiCo 'Stretches' Managers At Top -- WSJ



07/27 LI KA-SHING : Li Ka-shing's CKI to buy German energy metering firm Ista



07/26DJBERNARD ARNAULT : LVMH's Profit Rises 24% in First Half



07/27 RUPERT MURDOCH : As Murdoch waits, Sky cuts operating costs to protect profits



07/26DJMEG WHITMAN : Meg Whitman Steps Down From HP Board



07/26DJDAVID SIMON : Executive Pay Falls for Big Mall Owners as Retail Storm Rages On



07/27DJJEFF BEZOS : Amazon's Jeff Bezos Becomes World's Richest Person



07/22DJWILBUR ROSS : More Cross-Border Commerce



07/24 URSULA BURNS : VEON names former Xerox CEO Ursula Burns as chairwoman



More news

 


            © 2017 People and Ownership :    









Advertisement








John Martin Docherty : Connections 



 Eurasia Energy Ltd









Nicholas W. Baxter




 Max Resource Corp









Leonard MacMillan




 Enertopia Corp









Baljinder Bhullar




 Lexaria Bioscience Corp









Christopher A. BunkaNicholas W. BaxterWilliam Edward McKechnieAllan Spissinger




 Napatech A/S









Howard Bubb




CAB Financial Services Ltd.
                                            








Christopher A. Bunka





Jericho Oil Corp
                                            








Nicholas W. Baxter





Sacramento Area Regional Technology Alliance
                                            








Howard Bubb





Bare Elegance MedSpa
                                            








Baljinder Bhullar





 







Popular Business Leaders 


 

Bernard Arnault
Mary Barra
Jeff Bezos
Lloyd Blankfein
Michael Bloomberg
Yannick Bolloré
Warren Buffett
Jean-paul Clozel
Gary Cohn
Jamie Dimon
Ralph Dommermuth
Sebastian Ebel
John Edwards
David Einhorn
Jeff Fettig
Mark Fields
Carlos Ghosn
Terry Gou
David Henry
Carl Icahn
Li Ka-shing
Michel Landel
Daniel Loeb
Jack Ma
Lakshmi Mittal
Rupert Murdoch
Elon Musk
Peter Nicholas
John Paulson
Nelson Peltz
Georges Plassat
Hasso Plattner
Thomas Rabe
Giuseppe Recchi
Wolfgang Reitzle
Wilbur Ross
Charles Schwab
Igor Sechin
Masayoshi Son
Pascal Soriot
George Soros
Rupert Stadler
Bernard Tapie
Patrick Thomas
Tim Westergren
John Williamson
Thomas Wilson
Dieter Zetsche
Mark Zuckerberg



A-Z Business Leaders




 



























4-traders.com :MarketsNewsAnalysisStock PicksPortfoliosScreenersWatchlistsTop / FlopToolsOur ServicesAbout :Surperformance SASContact usAdvertiseLegal informationsAbout usStay Connected :FacebookTwitterPartners :Börse: Aktien, Kurse und NachrichtenBest tweets 




   Copyright © 2017 Surperformance. All rights reserved.  












 














Slave





